Experience with the levonorgestrel-releasing intrauterine system among HIV-infected women.


BACKGROUND Safe and effective contraception is needed for women infected with human immunodeficiency virus (HIV). The levonorgestrel-releasing intrauterine system (LNG-IUS) is an effective long-term contraceptive that reduces menstrual bleeding and may reduce the risk of pelvic inflammatory disease. Yet, little is known about LNG-IUS use in HIV-infected women. SUBJECTS AND METHODS Six HIV-infected women had the LNG-IUS inserted between March 1998 and October 2002, and were systemically followed for a mean of 45 months. Indications for LNG-IUS use were contraception in four women and menorrhagia in two women. RESULTS The LNG-IUS was well tolerated, and menstrual bleeding was reduced in all women. Blood hemoglobin levels increased in each subject, with mean levels being 123 g/L (SD=11.7) before LNG-IUS insertion and 135 g/L (SD=8.7) at 1 year (p=.01). Levels of circulating CD4 lymphocytes and Pap smear findings remained unchanged. CONCLUSIONS Our limited experience with LNG-IUS use in HIV-infected women is encouraging. The LNG-IUS may be used as an alternative to uterine surgery in HIV-infected women with menorrhagia.


Citations per Year

74 Citations

Semantic Scholar estimates that this publication has 74 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Lehtovirta2007ExperienceWT, title={Experience with the levonorgestrel-releasing intrauterine system among HIV-infected women.}, author={P{\"a}ivi Lehtovirta and Jorma Paavonen and Oskari Heikinheimo}, journal={Contraception}, year={2007}, volume={75 1}, pages={37-9} }